Investment
Features
FeesSafety
Academy
More
Pluang+

Glaukos reports 50% sales growth in Q2, raises 2026 sales forecast amid new drug launches and Medicare risks.

Company Fundamentals
09 Oct 2026
Seeking Alpha
View Source
Bullish
Glaukos reports 50% sales growth in Q2, raises 2026 sales forecast amid new drug launches and Medicare risks.

Glaukos saw a 50% year-over-year increase in Q2 net sales to $185.6 million, driven by its iDose TR product and the launch of Epioxa. The company now operates with strong gross margins of 85% and a breakeven profit and loss statement. Management raised its 2026 net sales guidance to $680–700 million, expecting iDose TR sales of $275–280 million and over 20% growth in corneal health products. However, there is some uncertainty due to potential Medicare coverage restrictions on iDose TR, though Epioxa's launch offers a new growth avenue.

Glaukos stock performance is presented here with Pluang's health sector data for context. For readers following health stocks, as of Oct 10, 2026 07:11 WIB, 109 of 128 health-sector US stocks on Pluang rose while 18 fell. Among notable movers, Definium Therapeutics Inc. (DFTX) gained 7.96% to USD 36.90 with 100% buy orders and zero typical hold time, ImmunityBio Inc. (IBRX) rose 6.05% to USD 10.51 with a typical hold time of 1 day, and Crispr Therapeutics AG (CRSP) increased 5.85% to USD 53.39 with a typical hold time of 77 days and 91% buy orders.

More News

Sigenergy debuts AI-powered energy solutions and new partnerships at Malaysia's IGEM 2026.

Sigenergy debuts AI-powered energy solutions and new partnerships at Malaysia's IGEM 2026.

At Malaysia's IGEM 2026, Sigenergy showcased its latest AI-driven energy technologies, including smart storage and inverter systems, highlighting its role in advancing sustainable energy. The company also signed MOUs with local partners Milieu and YT...

Market News
Bullish
3 hours ago
Binance Coin (BNB) trades near $748 amid mixed signals and possible 25% drop forecast.

Binance Coin (BNB) trades near $748 amid mixed signals and possible 25% drop forecast.

Binance Coin (BNB) traded around $748 on October 10, showing a slight 0.78% increase over 24 hours but facing short-term selling pressure. The token remains above its 50-day and 200-day moving averages, indicating some longer-term support, while shor...

Technical Signals
Neutral
4 hours ago
Prediction markets give Bitcoin only a 2% chance to hit $200,000 in 2026, a record low.

Prediction markets give Bitcoin only a 2% chance to hit $200,000 in 2026, a record low.

Prediction markets like Kalshi and Polymarket now assign just a 2% probability that Bitcoin will reach $200,000 by January 1, 2027, marking a record low for such contracts. Currently trading around $82,000 to $84,000, Bitcoin would need to more than ...

Market News
Neutral
4 hours ago
NFT sales rise to $39.85M led by Ethereum and Pudgy Penguins' 125% gain

NFT sales rise to $39.85M led by Ethereum and Pudgy Penguins' 125% gain

NFT trading volume increased to nearly $40 million in the week through Oct. 10, driven by Ethereum blockchain sales and a strong surge in Pudgy Penguins NFTs, which saw a 125.66% sales increase. Despite fewer buyers and sellers, total sales rose, ind...

Market News
Bullish
4 hours ago
Ether trades below key moving averages amid higher sell volume on Binance futures.

Ether trades below key moving averages amid higher sell volume on Binance futures.

Ether (ETH) traded around $2,492 on Binance, staying below its short-term moving averages as sell volume in futures exceeded buy volume. The 24-hour range was $2,474 to $2,520, with open interest slightly down, indicating some position closures. Desp...

Technical Signals
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App